<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-170-10-66-71</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-1177</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДИСКУССИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DISCUSSION</subject></subj-group></article-categories><title-group><article-title>Виром кишечника и язвенный колит: новые грани взаимодействия</article-title><trans-title-group xml:lang="en"><trans-title>Virom of intestinal canal and ulcerative colitis: new facets of interaction</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бикбавова</surname><given-names>Г. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Bikbavova</surname><given-names>G. R.</given-names></name></name-alternatives><email xlink:type="simple">galiya1976@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ливзан</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Livzan</surname><given-names>M. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Заставная</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zastavnaya</surname><given-names>A. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Омский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Omsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>20</day><month>10</month><year>2019</year></pub-date><volume>1</volume><issue>10</issue><fpage>66</fpage><lpage>71</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бикбавова Г.Р., Ливзан М.А., Заставная А.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Бикбавова Г.Р., Ливзан М.А., Заставная А.А.</copyright-holder><copyright-holder xml:lang="en">Bikbavova G.R., Livzan M.A., Zastavnaya A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/1177">https://www.nogr.org/jour/article/view/1177</self-uri><abstract><p>Совокупность различных факторов образа жизни в эпоху постиндустриального общества оказывают существенное влияние на микробный пейзаж кишечника и приводит к изменению разнообразия его микробиоты при язвенном колите. Новые технологии секвенирования нуклеиновых кислот, инновационной статистики и биоинформатики постепенно меняют представления о этиологии и патогенезе ряда заболеваний, к которым относится и язвенный колит. Современные исследования демонстрируют, что помимо бактерий микробиота толстой кишки представлена эукариотическими и прокариотическими вирусами, которые вместе образуют виром кишечника и являются важной частью его микробной экосистемы. В условиях физиологического стресса количество бактериофагов и вирусов увеличивается, что приводит к нарушению всего динамического равновесия микробиоты желудочно-кишечного тракта. Открытие специфических микроорганизмов, ассоциированных с язвенным колитом прольет свет на его этиологию и позволит создать новые таргетные методы его лечения. Целью данного обзора является обобщение имеющейся информации об участии вирома в возникновении язвенного колита. Поиск литературы, содержащей информацию о соответствующих исследованиях проводился в системах PubMed и GoogleScholar по ключевым словам: язвенный колит, виром кишечника, микробиота толстой кишки. На сегодняшний день в литературе имеются малочисленные, но ценные сведения по данному вопросу, что требует дальнейшего накопления научных данных с последующей систематизацией полученной информации.</p></abstract><trans-abstract xml:lang="en"><p>Various lifestyle facts influence on microbial landscape of gut and change variety of microbiota with ulcerative colitis. New technologies of nucleotide sequencing, innovating statistics and bioinformatics grade into presentation about etiology and pathogenesis of some illness, for example ulcerative colitis. Current studies demonstrate that microbiome of gut acquaint with eukaryotic and prokaryotic viruses, which make virome of gut and be much part of microbial eco-system of intestinal tract. Number of bacteriophages and viruses escalete in the context of environmental stress so microbiome of the digestive tract disturbed. When we open specific microbiota, which associated with etiology of ulcerative colitis, we will create new treatment modality. Drive of this review is generalization of information about involvement with virome in ulcerative colitis becoming. For searching the literature were use systems PubMed and GoogleScholar with keywords: ulcerative colitis, gut virome, gut microbiome. Nowadays in the literature have limited but necessary information about this question. It requires accumulation scientifi c facts for integrated data.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>язвенный колит</kwd><kwd>микробиота кишечника</kwd><kwd>виром кишечника</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ulcerative colitis</kwd><kwd>gut virome</kwd><kwd>gut microbiome</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ng S.C., Shi H. Y., Hamidi N., et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet –2018. – P. 390. DOI: https://doi.org/10.1016/s0140–6736(17)32448–0</mixed-citation><mixed-citation xml:lang="en">Ng S.C., Shi H. Y., Hamidi N., et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet –2018. – P. 390. DOI: https://doi.org/10.1016/s0140–6736(17)32448–0</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Th e global, regional, and national burden of infl ammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 GBD2017 Infl ammatory Bowel Disease Collaborators Show footnotes Open Access Published. – 2019. DOI: https://doi.org/10.1016/S2468–1253(19)30333–4</mixed-citation><mixed-citation xml:lang="en">Th e global, regional, and national burden of infl ammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 GBD2017 Infl ammatory Bowel Disease Collaborators Show footnotes Open Access Published. – 2019. DOI: https://doi.org/10.1016/S2468–1253(19)30333–4</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplan G.G., Ng S. C. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. –2017. – P. 152:313–21. DOI: https://doi.org/10.1053/j.gastro.2016.10.020</mixed-citation><mixed-citation xml:lang="en">Kaplan G.G., Ng S. C. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. –2017. – P. 152:313–21. DOI: https://doi.org/10.1053/j.gastro.2016.10.020</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res ClinGastroenterol. – 2014. – P. 28:363–372. DOI: https://doi.org/10.1016/j.bpg.2014.04.003</mixed-citation><mixed-citation xml:lang="en">Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res ClinGastroenterol. – 2014. – P. 28:363–372. DOI: https://doi.org/10.1016/j.bpg.2014.04.003</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kaistha A., levine J. inf lammatory bowel disease: the classic gastrointestinal autoimmune disease. CurrProblPediatrAdolesc Health Care – 2014. – P. 44:328– 34. DOI: https://doi.org/10.1016/j.cppeds.2014.10.003</mixed-citation><mixed-citation xml:lang="en">Kaistha A., levine J. inf lammatory bowel disease: the classic gastrointestinal autoimmune disease. CurrProblPediatrAdolesc Health Care – 2014. – P. 44:328– 34. DOI: https://doi.org/10.1016/j.cppeds.2014.10.003</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cani P.D., Everard A. Talking microbes: when gut bacteria interact with diet and host organs. MolNutr Food Res – 2016. – P. 60:58–66. DOI: https://doi.org/10.1002/mnfr.201500406</mixed-citation><mixed-citation xml:lang="en">Cani P.D., Everard A. Talking microbes: when gut bacteria interact with diet and host organs. MolNutr Food Res – 2016. – P. 60:58–66. DOI: https://doi.org/10.1002/mnfr.201500406</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Costello E.K., Stagaman K., Dethlefsen L., Bohannan B. J., Relman D. A. Th e application of ecological theory toward an understanding of the human microbiome. Science. – 2012. – P. 336:1255–1262. DOI: https://doi.org/10.1126/science.1224203</mixed-citation><mixed-citation xml:lang="en">Costello E.K., Stagaman K., Dethlefsen L., Bohannan B. J., Relman D. A. Th e application of ecological theory toward an understanding of the human microbiome. Science. – 2012. – P. 336:1255–1262. DOI: https://doi.org/10.1126/science.1224203</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Arora T., Bäckhed F. The gut microbiota and metabolic disease: current understanding and future perspectives J. Intern. Med. – 2016. – Vol. 280. № 4. P. 339–349. DOI: https://doi.org/10.1111/joim.12508</mixed-citation><mixed-citation xml:lang="en">Arora T., Bäckhed F. The gut microbiota and metabolic disease: current understanding and future perspectives J. Intern. Med. – 2016. – Vol. 280. № 4. P. 339–349. DOI: https://doi.org/10.1111/joim.12508</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Qin J., Li R., Raes J., Arumugam M., Burgdorf K. S., Manichanh C. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. – 2010. – P. 464:59–65. DOI: https://doi.org/10.1038/nature08821</mixed-citation><mixed-citation xml:lang="en">Qin J., Li R., Raes J., Arumugam M., Burgdorf K. S., Manichanh C. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. – 2010. – P. 464:59–65. DOI: https://doi.org/10.1038/nature08821</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Minot S., Grunberg S., Wu G. D., Gd W., et al. Hy per vari able loci in the human gut virome. ProcNatlAcadSci U S A – 2012. – P. 109:3962–6. DOI: https://doi.org/10.1073/pnas.1119061109</mixed-citation><mixed-citation xml:lang="en">Minot S., Grunberg S., Wu G. D., Gd W., et al. Hy per vari able loci in the human gut virome. ProcNatlAcadSci U S A – 2012. – P. 109:3962–6. DOI: https://doi.org/10.1073/pnas.1119061109</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tito R.Y., Chaffron S., Caenepeel C., et al. Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota. Gut. gutjnl – 2018. DOI: https://doi.org/10.1136/gutjnl-2018–316106</mixed-citation><mixed-citation xml:lang="en">Tito R.Y., Chaffron S., Caenepeel C., et al. Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota. Gut. gutjnl – 2018. DOI: https://doi.org/10.1136/gutjnl-2018–316106</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Palma M.L., Zamith-Miranda D., Martins F. S., et al. Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: Is there room for improvement? ApplMicrobiolBiotechnol. – 2015. – P. 99: 6563–6570. DOI: https://doi.org/10.1007/s00253–015–6776-x</mixed-citation><mixed-citation xml:lang="en">Palma M.L., Zamith-Miranda D., Martins F. S., et al. Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: Is there room for improvement? ApplMicrobiolBiotechnol. – 2015. – P. 99: 6563–6570. DOI: https://doi.org/10.1007/s00253–015–6776-x</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sokol H., Leducq V., Aschard H., et al. Fungal microbiotadysbiosis in IBD. Gut. – 2017. – P. 66: 1039–1048. DOI: https://doi.org/10.1136/gutjnl-2015–310746</mixed-citation><mixed-citation xml:lang="en">Sokol H., Leducq V., Aschard H., et al. Fungal microbiotadysbiosis in IBD. Gut. – 2017. – P. 66: 1039–1048. DOI: https://doi.org/10.1136/gutjnl-2015–310746</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gaci N., Borrel G., Tottey W., et al. Archaea and the human gut: New beginning of an old story. World J Gastroenterol. – 2014. – P. 20: 16062–16062. DOI: https://doi.org/10.3748/wjg.v20.i43.16062</mixed-citation><mixed-citation xml:lang="en">Gaci N., Borrel G., Tottey W., et al. Archaea and the human gut: New beginning of an old story. World J Gastroenterol. – 2014. – P. 20: 16062–16062. DOI: https://doi.org/10.3748/wjg.v20.i43.16062</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Borrel G., McCann A., Deane J., et al. Genomics and metagenomics of trimethylamine-utilizing Archaea in the human gut microbiome. ISME. – 2017. – P. 11: 2059–2074. DOI: https://doi.org/10.1038/ismej.2017.72</mixed-citation><mixed-citation xml:lang="en">Borrel G., McCann A., Deane J., et al. Genomics and metagenomics of trimethylamine-utilizing Archaea in the human gut microbiome. ISME. – 2017. – P. 11: 2059–2074. DOI: https://doi.org/10.1038/ismej.2017.72</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Vianna M.E., Conrads G., Gomes B. P.F.A., et al. Identificati on and quantification of archaea involved in primary endodontic infections. J ClinMicrobiol. – 2006. – P. 44: 1274–1282. DOI: https://doi.org/10.1128/jcm.44.4.1274–1282.2006</mixed-citation><mixed-citation xml:lang="en">Vianna M.E., Conrads G., Gomes B. P.F.A., et al. Identificati on and quantification of archaea involved in primary endodontic infections. J ClinMicrobiol. – 2006. – P. 44: 1274–1282. DOI: https://doi.org/10.1128/jcm.44.4.1274–1282.2006</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Manrique P., Bolduc B., Walk S. T., van der Oost J., de Vos W. M., Young M. J. (2016). Healthy human gut phageome. Proc. Natl. Acad. Sci. USA. – 2016. – P. 113: 10400– 10405. DOI: https://doi.org/10.1073/pnas.1601060113</mixed-citation><mixed-citation xml:lang="en">Manrique P., Bolduc B., Walk S. T., van der Oost J., de Vos W. M., Young M. J. (2016). Healthy human gut phageome. Proc. Natl. Acad. Sci. USA. – 2016. – P. 113: 10400– 10405. DOI: https://doi.org/10.1073/pnas.1601060113</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Popgeorgiev N., Temmam S., Raoult D. et al. Describing the Silent Human Virome with an Emphasis on Giant Viruses. Intervirology. – 2013. – P. 56: 395–412. DOI: https://doi.org/10.1159/000354561</mixed-citation><mixed-citation xml:lang="en">Popgeorgiev N., Temmam S., Raoult D. et al. Describing the Silent Human Virome with an Emphasis on Giant Viruses. Intervirology. – 2013. – P. 56: 395–412. DOI: https://doi.org/10.1159/000354561</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Virgin H. W. The virome in mammalian physiology and disease. Cell – 2014. – P. 157:142–50. DOI: https://doi.org/10.1016/j.cell.2014.02.032</mixed-citation><mixed-citation xml:lang="en">Virgin H. W. The virome in mammalian physiology and disease. Cell – 2014. – P. 157:142–50. DOI: https://doi.org/10.1016/j.cell.2014.02.032</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Reyes A., Haynes M., Hanson N., et al. Viruses in the faecalmicrobiota of monozygotic twins and their mothers. Nature – 2010. – P. 466:334–8.DOI: https://doi.org/10.1038/nature09199</mixed-citation><mixed-citation xml:lang="en">Reyes A., Haynes M., Hanson N., et al. Viruses in the faecalmicrobiota of monozygotic twins and their mothers. Nature – 2010. – P. 466:334–8.DOI: https://doi.org/10.1038/nature09199</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Parker M. T. An ecological framework of the human virome provides classifi cation of current knowledge and identifies areas of forthcoming discovery. Yale J. Biol. Med. Collection – 2016. – P. 89: 339–351. DOI: https://doi.org/10.1109/fskd.2016.7603347</mixed-citation><mixed-citation xml:lang="en">Parker M. T. An ecological framework of the human virome provides classifi cation of current knowledge and identifies areas of forthcoming discovery. Yale J. Biol. Med. Collection – 2016. – P. 89: 339–351. DOI: https://doi.org/10.1109/fskd.2016.7603347</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Carding S.R., Davis N., Hoyles L. (2017). Review article: the human intestinal virome in health and disease. Aliment PharmacolTher. – 2017. – P. 46(9): 800–815. DOI: https://doi.org/10.1111/apt.14280</mixed-citation><mixed-citation xml:lang="en">Carding S.R., Davis N., Hoyles L. (2017). Review article: the human intestinal virome in health and disease. Aliment PharmacolTher. – 2017. – P. 46(9): 800–815. DOI: https://doi.org/10.1111/apt.14280</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Minot S., Wu G. D., Lewis J. D., and Bushman F. D. (2012a). Conservation of gene cassettes among diverse viruses of the human gut. PLoS ONE. – 2012. DOI: https://doi.org/10.1371/journal.pone.0042342</mixed-citation><mixed-citation xml:lang="en">Minot S., Wu G. D., Lewis J. D., and Bushman F. D. (2012a). Conservation of gene cassettes among diverse viruses of the human gut. PLoS ONE. – 2012. DOI: https://doi.org/10.1371/journal.pone.0042342</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Cadwell K. The virome in host health and disease. Immunity. – 2015. – P. 42:805–13. DOI: https://doi.</mixed-citation><mixed-citation xml:lang="en">Cadwell K. The virome in host health and disease. Immunity. – 2015. – P. 42:805–13. DOI: https://doi.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">org/10.1016/j.immuni.2015.05.003</mixed-citation><mixed-citation xml:lang="en">org/10.1016/j.immuni.2015.05.003</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Hoyles L., McCartney A.L., Neve H., Gibson G. R., Sanderson J. D., Heller K. J., van Sinderen D. Cha racterization of virus-like particles associated with the human faecal and caecal microbiota. Res. Microbiol. – 2014. – P. 165: 803–812. DOI: https://doi.org/10.1016/j.resmic.2014.10.006</mixed-citation><mixed-citation xml:lang="en">Hoyles L., McCartney A.L., Neve H., Gibson G. R., Sanderson J. D., Heller K. J., van Sinderen D. Cha racterization of virus-like particles associated with the human faecal and caecal microbiota. Res. Microbiol. – 2014. – P. 165: 803–812. DOI: https://doi.org/10.1016/j.resmic.2014.10.006</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Parker M. T. An ecological framework of the human virome provides classification of current knowledge and identifies areas of forthcoming discovery. Yale J. Biol. Med. Collection – 2016. – P. 89: 339–351. DOI: https://doi.org/10.1109/fskd.2016.7603347</mixed-citation><mixed-citation xml:lang="en">Parker M. T. An ecological framework of the human virome provides classification of current knowledge and identifies areas of forthcoming discovery. Yale J. Biol. Med. Collection – 2016. – P. 89: 339–351. DOI: https://doi.org/10.1109/fskd.2016.7603347</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Reyes A., Semenkovich N. P., Whiteson K., Rohwer F. and Gordon, J. I. (2012). Going viral, next-generation sequencing applied to phage populations in the human gut. Nat. Rev. Microbio. – 2012. – P. 10, 607–617. DOI: https://doi.org/10.1038/nrmicro2853</mixed-citation><mixed-citation xml:lang="en">Reyes A., Semenkovich N. P., Whiteson K., Rohwer F. and Gordon, J. I. (2012). Going viral, next-generation sequencing applied to phage populations in the human gut. Nat. Rev. Microbio. – 2012. – P. 10, 607–617. DOI: https://doi.org/10.1038/nrmicro2853</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Castro-Mejia J.L., Muhammed M. K., Kot W., Neve H., Franz C. M., Hansen L. H., Vogensen F. K., Nielsen D. S. Optimizing protocols for extraction of bacteriophages prior to metagenomic analyses 54. of phage communities in the human gut. Microbiome. – 2015. – P. 3: 64. DOI: https://doi.org/10.1186/s40168–015–0131–4</mixed-citation><mixed-citation xml:lang="en">Castro-Mejia J.L., Muhammed M. K., Kot W., Neve H., Franz C. M., Hansen L. H., Vogensen F. K., Nielsen D. S. Optimizing protocols for extraction of bacteriophages prior to metagenomic analyses 54. of phage communities in the human gut. Microbiome. – 2015. – P. 3: 64. DOI: https://doi.org/10.1186/s40168–015–0131–4</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Zuo T., Lu X., Zhang Y., et al Gut mucosal virome alterations in ulcerative colitis Gut – 2019. – P. 68:1169–1179. DOI: https://doi.org/10.1136/gutjnl-2018–318131</mixed-citation><mixed-citation xml:lang="en">Zuo T., Lu X., Zhang Y., et al Gut mucosal virome alterations in ulcerative colitis Gut – 2019. – P. 68:1169–1179. DOI: https://doi.org/10.1136/gutjnl-2018–318131</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Norman, J. M. et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. – 2015. DOI: https://doi.org/10.3410/f.725326230.793504965</mixed-citation><mixed-citation xml:lang="en">Norman, J. M. et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. – 2015. DOI: https://doi.org/10.3410/f.725326230.793504965</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Uhr J.W., Dancis J., Franklin E. C., Finkelstein M. S., Lewis E. W. The antibody response to bacteriophage phi-X 174 in newborn premature infants. The Journal of clinical investigation. – 1962. – P. 41:1509–1513. DOI: https://doi.org/10.1172/jci104606</mixed-citation><mixed-citation xml:lang="en">Uhr J.W., Dancis J., Franklin E. C., Finkelstein M. S., Lewis E. W. The antibody response to bacteriophage phi-X 174 in newborn premature infants. The Journal of clinical investigation. – 1962. – P. 41:1509–1513. DOI: https://doi.org/10.1172/jci104606</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Eriksson F., Tsagozis P., Lundberg K., Parsa R., Mangsbo S. M., Persson M. A.A., Harris R. A., Pisa P. Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages. The Journal of Immunology. – 2009. – P. 182:3105–3111. DOI: https://doi.org/10.4049/jimmunol.0800224</mixed-citation><mixed-citation xml:lang="en">Eriksson F., Tsagozis P., Lundberg K., Parsa R., Mangsbo S. M., Persson M. A.A., Harris R. A., Pisa P. Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages. The Journal of Immunology. – 2009. – P. 182:3105–3111. DOI: https://doi.org/10.4049/jimmunol.0800224</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Basic M., Keubler L. M., Buettner M., Achard M., Breves G., Schroder B., Smoczek A., Jorns A., Wedekind D., Zschemisch N. H., et al. Norovirus Triggered Microbiota-driven Mucosal Inflammation in Interleukin 10-deficient Mice. Inflammatory bowel diseases. – 2014. – P. 20:431–443. DOI: https://doi.org/10.1097/01.mib.0000441346.86827.ed</mixed-citation><mixed-citation xml:lang="en">Basic M., Keubler L. M., Buettner M., Achard M., Breves G., Schroder B., Smoczek A., Jorns A., Wedekind D., Zschemisch N. H., et al. Norovirus Triggered Microbiota-driven Mucosal Inflammation in Interleukin 10-deficient Mice. Inflammatory bowel diseases. – 2014. – P. 20:431–443. DOI: https://doi.org/10.1097/01.mib.0000441346.86827.ed</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">De Souza H. S., Fiocchi C. Immunopathogenesis of IBD: Current state of the art. Nat. Rev. GastroenterolHepatol. – 2016. – P. 13, 13–27. DOI: https://doi.org/10.1038/nrgastro.2015.186</mixed-citation><mixed-citation xml:lang="en">De Souza H. S., Fiocchi C. Immunopathogenesis of IBD: Current state of the art. Nat. Rev. GastroenterolHepatol. – 2016. – P. 13, 13–27. DOI: https://doi.org/10.1038/nrgastro.2015.186</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Rizzatti G., Lopetuso L. R., Gibiino G., Binda C., Gasbarrini A. Proteobacteria: A Common Factor in Human Diseases. BioMed Res. Int. – 2017. DOI: https://doi.org/10.1155/2017/9351507</mixed-citation><mixed-citation xml:lang="en">Rizzatti G., Lopetuso L. R., Gibiino G., Binda C., Gasbarrini A. Proteobacteria: A Common Factor in Human Diseases. BioMed Res. Int. – 2017. DOI: https://doi.org/10.1155/2017/9351507</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
